Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Dulcolax
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 245
2018 Revenue in Millions : 235
Growth (%) : 4
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 284
2019 Revenue in Millions : 272
Growth (%) : 4
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 244
2017 Revenue in Millions : 238
Growth (%) : 2%
Main Therapeutic Indication : OTC
Currency : USD
2014 Revenue in Millions : 5%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?